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We studied the viral etiology of acute expiratory
wheezing (bronchiolitis, acute asthma) in 293 hospitalized
children in a 2-year prospective study in Finland. A poten-
tial causative viral agent was detected in 88% of the cases.
Eleven different viruses were represented. Respiratory syn-
cytial virus (RSV) (27%), enteroviruses (25%), rhinovirus
(24%), and nontypable rhino/enterovirus (16%) were found
most frequently. In infants, RSV was found in 54% and res-
piratory picornaviruses (rhinovirus and enteroviruses) in
42% of the cases. In older children, respiratory picor-
naviruses dominated (65% of children ages 1–2 years and
82% of children ages >3 years). Human metapneumovirus
was detected in 4% of all children and in 11% of infants. To
prevent and treat acute expiratory wheezing illnesses in
children, efforts should be focused on RSV, enterovirus,
and rhinovirus infections.
A
cute expiratory wheezing illnesses (bronchiolitis,
acute asthma) are the primary causes of
hospitalization in children. An estimated 3% of children
without other medical conditions are hospitalized for
bronchiolitis (1). The annual hospitalization rate for
exacerbation of asthma is 0.15% in children (2). In the
United States alone, ≈200,000 children are hospitalized for
bronchiolitis and acute asthma each year, which causes a
substantial impact on families and the community. 
Respiratory viruses are the most important precipitants
of acute expiratory wheezing in children (3,4).
Bronchiolitis is reportedly induced in infants mainly by
respiratory syncytial virus (RSV), and asthma in older
children is induced mainly by rhinovirus. The role of rhi-
novirus in infants is not clear. Furthermore, the roles of
other respiratory viruses, e.g., enteroviruses, and the
recently discovered human metapneumovirus (HMPV) in
the etiology of acute wheezing are not well established
(5,6). Investigating the viral origin of acute expiratory
wheezing is useful because some antiviral treatments and
vaccination are available, and the efficacy of anti-inflam-
matory treatments may be related to viral origin. 
The purpose of the study was to investigate the role of
11 respiratory viruses in children hospitalized for acute
expiratory wheezing. The viral etiology was studied for 2
years prospectively to cover outbreaks of all major respira-
tory viruses. Virus culture, virus antigen detection, poly-
merase chain reaction (PCR) techniques, and serologic
testing were used to optimize the diagnosis of viral infec-
tion. 
Methods
Study Participants and Definitions
As part of a randomized clinical trial evaluating the
efficacy of systemic corticosteroid in the treatment of
acute expiratory wheezing in children, we investigated the
viral etiology of the infections. From September 1, 2000,
through May 31, 2002, a total of 293 children participated
in the study in the Department of Pediatrics, Turku
University Hospital. Study breaks occurred from June to
July 2001 and during Christmas week 2001. Inclusion cri-
teria were the following: age from 3 months to 16 years,
hospitalization for acute expiratory wheezing, and written
informed consent from the parents. Exclusion criteria were
the following: chronic diseases other than asthma or aller-
gy, systemic glucocorticoid treatment within 4 weeks
before the study, severe wheezing necessitating intensive-
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Acute expiratory wheezing was called bronchiolitis
when it occurred in children <3 years of age. When it
recurred >2 times in persons of any age or occurred in per-
sons >3 years of age, the diagnosis of asthma was used (7).
To some extent, bronchiolitis and asthma are expressions
of the same pathologic process, and no rigid criteria sepa-
rate these illnessess. All patients were examined by one of
the two study physicians (T.J. and P.L.). 
Sample Collection 
On patient’s admission, a nasopharyngeal aspirate
sample was taken through a nostril by inserting a
disposable catheter connected to a mucus extractor to a
depth of 5 to 7 cm and retracting it slowly while applying
gentle suction with an electric suction device. All
specimens were obtained without inserting any solution
into the nostrils. Disposable plastic gloves were used, and
all surfaces were wiped with disinfectant to prevent
contamination. Immediately after the secretion was
suctioned, two sterile cotton swabs were dipped in the
aspirate. The swabs were then placed in vials containing 2
mL of viral transport medium (5% tryptose phosphate
broth, 0.5% bovine serum albumin, and antimicrobial
agents in phosphate-buffered saline) for virus culture and
PCR assays. The rest of the mucus was used for virus
antigen detection. The specimens were transported to the
laboratory on the same day at room temperature. The tubes
for RSV and HMPV PCR assays were frozen at –70°C
before processing. Blood samples were collected on
patient’s admission and 2–3 weeks after discharge from the
hospital.
Virologic Methods
Viral antigens for adenovirus; influenza A and B virus-
es; parainfluenza virus types 1, 2, and 3; and RSV were
detected by time-resolved fluoroimmunoassay (8).
Immunoglobulin (Ig) G antibodies to the same viruses
were measured from paired serum samples by enzyme
immunoassays as described earlier (9–11). Purified heat-
treated coxsackievirus A9, coxsackievirus B3, echovirus
11, and poliovirus 1 were used as an antigen mixture in
enterovirus IgG assays and purified heat-treated coxsack-
ievirus A16, coxsackievirus B3, and echovirus 11 in IgM
assays (12). Virus culture was performed according to rou-
tine protocols in A549, HeLa, and LLC-Mk2 cell lines and
human foreskin fibroblasts (13). The supernatants of cell
cultures exhibiting a cytopathogenic effect were further
studied by antigen detection for adenovirus; influenza A
and B viruses; parainfluenza virus types 1, 2, and 3; and
RSV or by reverse transcription (RT)-PCR for enterovirus-
es and rhinovirus. Nucleic acids for RT-PCR were isolated
from the nasopharyngeal samples with a commercial kit
(High Pure Viral Nucleic Acid Kit, Roche Diagnostics,
Mannheim, Germany) according to the manufacturer’s
instructions. RT-PCR was used to detect enteroviruses and
rhinovirus, coronavirus, RSV, and HMPV, as described
previously (6,14,15). A case was defined as virus positive
if at least one of the tests used was positive for virus. The
rates of HMPV, respiratory picornaviruses, and RSV
detected during the first study season 2000–2001 have
been published (16).
Statistical Methods
The chi-square test was used for intergroup
comparisons of differrent age groups in specific virus
groups. The results were analyzed by using SAS software
(version 8.2, SAS Institute, Cary, NC). 
Results
Patient Characteristics
From September 2000 through May 2002, a total of
661 children were hospitalized for acute expiratory wheez-
ing (Figure 1). Of the 661 patients, 341 did not meet the
study criteria: 87 had already participated in the study, 79
were <3 months of age, 55 were not enrolled during study
breaks, 48 had had systemic glucocorticoid treatment with-
in 4 weeks, 24 did not need hospitalization, 17 had a
chronic disease, 12 had guardians with language difficul-
ties, 11 needed treatment in our intensive care unit, 3 had
guardians who were not present, 2 were exposed to vari-
cella, 2 patients’ cases were not reported to the study
physician, and 1 child was not eligible because of social
reasons. The remaining 320 were eligible, but the parents
of 27 (8%) children did not give their consent for partici-
pation in the study. Eventually, 293 children participated in
the study.
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Figure 1. Hospitalized children with expiratory wheezing during the
study period. Black indicates included patients.The median age of the 293 study patients was 1.6 years
(range 3 months–15.2 years). Seventy-six (26%) children
were <12 months of age, 152 (52%) children were 12–35
months old, and 65 (22%) children were >3 years. In 179
children, the clinical diagnosis was bronchiolitis and in
114, acute asthma. Of the children with asthma, 49 were
<3 years of age, 53% were boys, 38% experienced atopy,
and 41% had parents who smoked.
Virus Infections
Apotential causative viral agent was detected in 88% of
the cases (Table 1). RSV (27%), enteroviruses (25%), and
rhinovirus (24%) were the most common causative agents,
resulting in 31%, 28%, and 28% of 258 virus-positive
cases, respectively. The viruses in samples identified by
the primary picornavirus PCR test but not identifiable in
the liquid-hybridization assay were named rhino/
enteroviruses (16%). According to our sequence data,
these amplicons have shown >90% homology to human
rhinoviruses. The remaining eight viruses studied account-
ed for 18% of the cases, and none of these viruses was
detected in >5% of all cases. 
Mixed viral infections were found in 57 (19%) cases
and were usually associated with respiratory picornavirus-
es. Coinfection with enteroviruses and RSV was the most
common mixed infection (19%), followed by rhinovirus
and RSV (14%), rhino/enterovirus and RSV (11%), and
enteroviruses and rhinovirus (9%). Of 12 HMPV infec-
tions, 5 were associated with other respiratory viruses.
Most of the viruses (84%), respiratory picornaviruses
especially, were detected by using PCR (Table 1).
Rhinovirus was cultivated in 25 (38%) of 65 specimens
with PCR-positive results, enteroviruses in 14 (24%) of 59
specimens with PCR-positive results, and rhino/
enterovirus in 1 (2%) of 46 specimens with PCR-positive
results. To compare different methods of detecting RSV
infection, we selected the patients whose samples were
studied with four methods (n = 257). The recovery rate of
RSV by IgG serologic testing was 22%; by virus antigen
detection, 21%; by virus culture, 20%; and by PCR, 18%. 
Seasonality of Virus Infections
Typical of the situation in Finland, a minor RSV
epidemic occurred during the spring of 2000, followed by
a major epidemic during the winter of 2001 to 2002
(Figure 2). Enterovirus outbreaks were seen during the fall
in both 2000 and 2001. Rhinovirus outbreaks occurred
during fall and spring of both years. An HMPV epidemic
was seen during the winter of 2001. HMPV was detected
in 30% of the study children during the 3-month epidemic.
During the peak 3 epidemic months of respiratory
picornaviruses, from September to November 2000, they
accounted for 82% of all cases, and only 5% had other
viral causes. During the peak 3 epidemic months of RSV,
from November 2001 through January 2002, RSV
accounted for 65% of all cases, and other viruses were
found in 20%. Influenza A virus epidemics occured in the
community from the beginning of October 2000 to the end
of March 2001 and from October 2001 to May 2002 (data
not shown), but influenza A virus caused only three cases
of acute expiratory wheezing for which the patient had to
be hospitalized.
Virus Infections by Age 
RSV (54%), respiratory picornaviruses (42%), and
HMPV (11%) were the most common viruses in infants
(Figure 3). Respiratory picornaviruses were detected in
65% and RSV in 22% of the cases in children ages 12–35
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Table 1. Positive viral findings in 293 children hospitalized for acute expiratory wheezing
a 
Virus 
Virus antigen test; 
n = 293 
Virus culture;  
n = 292 
Virus PCR;
b  
n = 291 
Virus serology;  
n = 266  Total; n = 293 
Respiratory syncytial virus (RSV)  62 (21)  58 (20)  50 (18)  56 (21)  80 (27) 
Enterovirus    14 (5)  59 (20)  27 (10)  72 (25) 
Rhinovirus    25 (9)  65 (22)    71 (24) 
Rhino/enterovirus    1 (0.3)  46 (16)    46 (16) 
Parainfluenza virus type 1  8 (3)  0      8 (3) 
Parainfluenza virus type 2  0  0    0  0 
Parainfluenza virus type 3  4 (1)  1 (0.3)      5 (2) 
Parainfluenza virus type 1 or 3        8 (3)  4 (1) 
Adenovirus  0  9 (3)    6 (2)  15 (5) 
Human metapneumovirus      12 (4)    12 (4) 
Influenza A virus  1 (0.3)  1 (0.3)    2 (0.8)  3 (1) 
Influenza B virus  4 (1)  2 (0.7)    2 (0.8)  4 (1) 
Coronavirus    0  4 (1)    4 (1) 
Mixed viral infection          57 (19) 
Total   79 (27)  111 (38)  236 (81)  101 (38)  258 (88) 
aData are presented as number of samples positive (% of evaluated samples). 
bFor RSV polymerase chain reaction (PCR), n = 279. months. In children aged >3 years, respiratory
picornaviruses (82%) were found most frequently. 
Comparisons between age groups showed that RSV (p
< 0.001) and HMPV (p = 0.0030) infected infants
significantly more often than children in other age groups,
adenovirus infected children ages 1–2 years significantly
more often (p = 0.022), and enteroviruses infected children
ages >3 years more often (p = 0.0018; Figure 3). No other
significant differences were found. 
Discussion
Our prospective study produced four notable findings.
First, respiratory virus infection was detected in up to 90%
of hospitalized children with acute expiratory wheezing.
Second, respiratory picornaviruses were commonly
associated with wheezing in infants. Third, one third of the
wheezing children ages >3 years were infected with
enteroviruses. Fourth, HMPV infections occurred in
infants, but mainly during the first study year, and they
were associated with only 4% of all cases with expiratory
wheezing.
All major studies of the viral origins of expiratory
wheezing are presented in Table 2. In studies from the
1960s to the 1990s, viral diagnosis was based on conven-
tional virus culture, antigen detection, and serologic test-
ing, and a viral agent could be established in 20% to 50%
of children with expiratory wheezing. Bronchiolitis was
mainly considered an RSV infection, with recovery in up
to 73% of patients with confirmed cases (30). Lower RSV
recovery rates were seen in older children
(17,18,21,22,24,27). In the 1990s, viral detection rates
increased to 75% to 85%, mainly as result of the increased
detection of rhinoviruses by PCR (3,5). Our data confirm
that RSV plays a key role in the etiology of bronchiolitis
during RSV epidemics. Our findings regarding bronchi-
olitis give a prominent role also to rhinovirus, which has
earlier been considered a common causative agent of
wheezing in older children only (3,4,28,31). We found no
differences in the distribution of rhinovirus infections by
patient age. 
This is the first long-term study to report a high
association of enterovirus infections with acute expiratory
wheezing in children. Enteroviruses, which replicate most
prolifically in the gastrointestinal tract, have recently been
shown to be associated with upper respiratory infections in
25% to 35% of the cases (32,33). Our findings are in
agreement with those of Rawlinson et al. (4), who found
enteroviruses by PCR in 29% of the young children with
well-documented asthma during the summer. We found
enteroviruses mostly in older children. 
HMPV was detected in 4% of our patients. A recent
study of children hospitalized for acute respiratory tract
disease found HMPVin 6% of the cases (34). Bronchiolitis
and pneumonitis were the main diagnoses. HMPV pre-
dominantly infected infants as seen in our study and in pre-
vious studies (4,6). HMPV outbreaks have been reported
mainly in mid-winter, which was supported by our study.
Notably, the HMPV outbreak with 10 cases was seen dur-
ing the first study year, and two cases were found during
the second year, which suggests that epidemics do not
occur every year.
The use of PCR has markedly increased the recovery
rates of viruses in acute respiratory infections (3,5). The
clinical value of positive respiratory picornavirus PCR
tests is, however, questionable as picornavirus RNA has
also been detected in 5% to 30% of asymptomatic children
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Figure 2. The epidemics of respiratory syncytial virus (red), rhi-
novirus (blue), enterovirus (green), and human metapneumovirus
(brown) during the study period. 
Figure 3. The prevalence of respiratory viruses in hospitalized,
wheezing children in different age groups. RSV, respiratory syncy-
tial virus; Rhino, rhinovirus; Rhi-Ent, rhino/enterovirus; Entero,
enteroviruses; HMPV, human metapneumovirus; Para 1–3,
parainfluenza virus types 1–3; Influ A/B, influenza A and B viruses;
Adeno, adenovirus; Corona, coronavirus; Mixed, mixed viral infec-
tion. p values are for intergroup comparisons: RSV p < 0.001,
HMPV p = 0.003, enteroviruses p = 0.0018, and adenovirus p =
0.022.(3,35). We recently found that the number of positive PCR
results for picornavirus markedly decreased over 2 to 3
weeks and disappeared over 5 to 6 weeks after an acute
respiratory infection, which suggests that a positive PCR
result for picornaviruses is related to acute infection (36).
None of the 79 healthy controls were infected with
enteroviruses, but 16% were positive for rhinovirus or
nontypeable rhino/enterovirus (36). In detecting RSV
infections, PCR was no more sensitive than virus culture,
antigen detection, or serologic testing. This finding is in
contrast to the results of previous studies, especially in
adults (37). In children too, PCR has been almost 1.5 times
more sensitive than culture and antigen detection (38).
These differences may be explained by the greater sensi-
tivity of the nested RT-PCR used in those studies.
Compared to children, adults may also have lower titers of
viruses in the nasopharynx, which favors PCR diagnosis
over virus culture or antigen detection. We likely did not
miss many cases of adenovirus, parainfluenza virus, or
influenza virus infections because PCR has only modestly
increased sensitivity to those viruses compared to virus
culture and antigen detection (39,40).
Our study has some limitations. First, and most impor-
tant, we studied fewer than half of the children admitted to
our hospital for acute expiratory wheezing. However,
throughout the study, we enrolled approximately half of
the patients hospitalized for expiratory wheezing each
month. Since the respiratory virus season is the main fac-
tor determining the viral cause of acute illness, any season-
ality bias is largely excluded. Several infants with RSV
infection were missed, because infants <3 months of age
were not included. However, during the summer study
break, when rhinovirus and enteroviruses are normally cir-
culating in the community, children were not enrolled.
This balances the ratio of missed RSV cases to picor-
navirus cases. We therefore believe that our sample reli-
ably represents the whole patient population hospitalized
during the study years. Furthermore, we only analyzed
viral infections. Chlamydia pneumoniae and Mycoplasma
pneumoniae have been detected in 5% to 25% of children
with acute wheezing, but the clinical importance of these
findings remains to be determined (7,28). 
In conclusion, this study showed that acute expiratory
wheezing necessitating hospitalization was most often
associated with RSV, enterovirus, and rhinovirus
infections. Acute expiratory wheezing in infants may be a
risk factor for childhood asthma (31). Therefore, efforts
should focus on developing antiviral agents and vaccines
against RSV and respiratory picornaviruses. 
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Table 2. Viral etiology of acute expiratory wheezing in children
a,b 
Methods for virus detection  Viral identification rates (%) 
Y of study 
(ref.) 
Wheezing 
episodes  Age (y)  Culture  Antigen  Serology  PCR  RSV  Rhino  Entero 
PIV 
types 
1–3 
Influ 
A/B  Adeno  Corona  HMPV 
Total 
pos. 
1965 (17)  225  0–16  +        8  3  5  4  0  4      27 
1971 (18)  855  0–14  +        9  2  1  8  1  2      25 
1975 (19)  1,515  0–12  +        3  12  3  3  2  1      23 
1976 (20)  267  1–12  +    +    4  6  1  1  1  3      14 
1979 (21)  1,851  0–15  +        7  1    6    2      21 
1979 (22)  554  0–12  +        2  13  4  4  2  1      26 
1979 (23)  72  5–15  +        1  28    3  10  1      49 
1984 (24)  256  2–15  +  +  +    5      4  2  3  2    29 
1987 (25)  204  0–12  +  +  +    6  1  5  0  3  2      19 
1993 (26)  99  0.2–16  +  +      14  19  3  0  2  0      36 
1996 (27)  181  0.3–2  +  +      12  6  1  7    2      26 
1999 (3)  70  0.2–16  +  +    +  26  61  1    1    4    83 
1999 (28)  132  0.3–14    +    +  21  47  10  4  5  5  5    82 
2000 (29)  84  0.7    +    +  54  10  8  0  0  13  0    74 
2002 (30)  118  0–1.5        +  53  21    3  3  8  3    74 
2003 (4)  179  0.1–17  +  +    +  7  79    1  2      2  88 
aSampling period of at least 12 mo. 
bRSV, respiratory syncytial virus; PCR, polymerase chain reaction; rhino, rhinovirus; entero, enterovirus, PIV, parainfluenza virus; influ, influenza virus; 
adeno, adenovirus; corona, coronavirus; HMPV, human metapnemovirus; pos., positive.  
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